Log In
CQMS
Make a Donation
Log In
Donate
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Mission and Values
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2026 Annual Scientific Meeting
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Donate or fundraise for TROG
    • Ways to Donate
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Mission and Values
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2026 Annual Scientific Meeting
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Donate or fundraise for TROG
    • Ways to Donate
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Strategic Plan 2020-2023
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Upcoming Trials
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Ways to Donate
    • Donate or fundraise for TROG
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Strategic Plan 2020-2023
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Upcoming Trials
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Ways to Donate
    • Donate or fundraise for TROG
    • TROG Ambassadors
  • Contact Us
Read our latest Annual Report highlighting TROG achievements
Read our Q & A with TROG Scientific Committee Chair A/Prof Hien Le
Get ready for World Radiotherapy Awareness Day 7 September
TROG ASM2026 - Abstracts now Open

CPRR04-EFC4690/TROG 02.02 – HEADSTART

    1. Home
    2. Trial
    3. CPRR04-EFC4690/TROG 02.02 – HEADSTART
  • By w.paterson
  • 14 August, 2021
  • 0 Comments
Completed
Head & Neck

"Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine (SR259075) Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer"

Primary Sponsor

Prev Post

TROG 03.02

Next Post

ANZMTG 01.02/TROG 02.01

Related Post

26 August, 2025

Welcome to new TROG committee members and thank you to long-serving members

LATEST NEWS: 26 August 2025 The TROG Scientific Committee

12 August, 2025

TROG 15.03/ANZUP 16001 FASTRACK II: economic analysis shows new technique is cheaper and more effective in the Australian setting

TRIAL UPDATE: 12 August 2025 Treating inoperable kidney cancer

Recent Posts

  • Welcome to new TROG committee members and thank you to long-serving members
  • TROG 15.03/ANZUP 16001 FASTRACK II: economic analysis shows new technique is cheaper and more effective in the Australian setting
  • World Lung Cancer Day: Focus on the TROG Lung Working Party
  • TROG 21.07 SOCRATES HCC Trial Expands Outreach
  • Major milestone for BIG 3-07/TROG 07.01 DCIS Study

Categories

  • Events 11
  • General 28
  • Journal 1
  • Participant Stories 12
  • Prostate Cancer 2
  • RAVES Trial 1
  • Trials 22
Register now

For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Facebook-f X-twitter Youtube Instagram Bluesky Streamline Icon: https://streamlinehq.com Bluesky

Quick Links

  • About Us
  • Our Research
  • Participants & Carers
  • Health & Research Professionals
  • News & Resources
  • Support Us
  • Contact Us

Legalities

  • Privacy Policy
  • Complaints & Feedback
  • Copyright Statement
  • Terms & Conditions
  • Cookie Warning
  • TROG Constitution

Latest News

Keep up to date with TROG news, subscribe to our community newsletter.

Subscribe

ABN:  45 132 672 292

TROG Cancer Research © 2025. All rights reserved

Website developed by the Marketing GP